Immune Tolerance Network   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Seattle WA United States (2000)

Organization Overview

First Clinical Trial
2001
NCT00014911
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Immune Tolerance Network (ITN)